Jonathan McNeill, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 1,274 shares at $16.11 ($20K) on 2021-09-21, disclosed to the SEC on 2021-09-22.
Scheduled sale ($20k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.61 | 545 | $9K | 42.0% |
| 2 | $16.11 | 729 | $12K | 58.0% |
| Total | $15.90 avg | 1,274 | $20K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |